Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib.

PLoS One · 2019 · PMC6438513 · PMID 30921351

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

We found that both mesothelin and E-cadherin expression significantly correlated to cetuximab sensitivity, and we observed a positive trend with β-Catenin expression.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.